Article Versions Notes

Witika BA, Poka MS, Demana PH, Matafwali SK, Melamane S, Malungelo Khamanga SM, Makoni PA. Lipid-Based Nanocarriers for Neurological Disorders: A Review of the State-of-the-Art and Therapeutic Success to Date. Pharmaceutics. 2022; 14(4):836. https://doi.org/10.3390/pharmaceutics14040836

Witika, Bwalya Angel, Madan Sai Poka, Patrick Hulisani Demana, Scott Kaba Matafwali, Siyabonga Melamane, Sandile Maswazi Malungelo Khamanga, and Pedzisai Anotida Makoni. 2022. "Lipid-Based Nanocarriers for Neurological Disorders: A Review of the State-of-the-Art and Therapeutic Success to Date" Pharmaceutics 14, no. 4: 836. https://doi.org/10.3390/pharmaceutics14040836

Witika, B. A., Poka, M. S., Demana, P. H., Matafwali, S. K., Melamane, S., Malungelo Khamanga, S. M., & Makoni, P. A. (2022). Lipid-Based Nanocarriers for Neurological Disorders: A Review of the State-of-the-Art and Therapeutic Success to Date. Pharmaceutics, 14(4), 836. https://doi.org/10.3390/pharmaceutics14040836